Nephrocare’s shares opened on a strong note in their stock market debut, signaling positive investor confidence in the healthcare company’s growth prospects and business fundamentals. The listing performance reflected healthy demand from both institutional and retail investors, supported by optimism around India’s expanding healthcare sector and rising focus on specialized medical services. Market participants viewed the debut as a validation of Nephrocare’s operating model, financial discipline and long-term potential.